US Price Control, Outcomes-Based Contracting: Reflections Of Former VA Secretary Shulkin
Executive Summary
The former Secretary of the US Department of Veterans Affairs, David Shulkin, discusses in an interview the US Inflation Reduction Act, telehealth, interoperability of healthcare data, and Mark Cuban’s pharma venture.
You may also be interested in...
Medicare Drug Payment Demonstration May Advance In 2023 Under Executive Order
Demonstration would ‘build on’ Medicare price controls established by the Inflation Reduction Act, White House says.
Medicare Drug Price Control Group Formed At CMS: How Will Stakeholders Interact?
As the Centers for Medicare and Medicaid Services begins the process of building new price negotiation and inflation rebate programs within Medicare, stakeholders are watching to see how transparent the process will be and how much outside input the agency will seek.
Medicare Price ‘Negotiation’ Process Could Enable National Value Framework – CMS’ Blum
Centers for Medicare and Medicaid Services chief operating officer Jonathan Blum discusses implementation of an unprecedented new price setting program and how it might impact value-based pricing more broadly in a recent interview with Health Affairs.